Intrinsiqs

Is Krystal Biotech, Inc. overvalued?

Krystal Biotech, Inc. (KRYS) — key valuation metrics and fundamentals.

No verdict
Price
$371.25
Fair value
Current P/E
Normal P/E
Market cap
$10.84B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares KRYS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.